1. [Home](https://www.g2.com/)
2. ...
3. [Emerging AI Software](https://www.g2.com/categories/emerging-ai-software)
4. [Humane Genomics Discussions](https://www.g2.com/products/humane-genomics/discuss)

[
 ![Product Avatar Image](https://images.g2crowd.com/uploads/product/image/large_detail/large_detail_ccb54c1e58f85ffc39aa41f5aa05bd03/humane-genomics.jpg "Product Avatar Image")
](/products/humane-genomics/reviews)

[

Humane Genomics

](/products/humane-genomics/reviews)

0 ratings

Humane Genomics is pioneering the development of oncolytic viral therapies by leveraging synthetic biology to engineer RNA viruses that selectively target and destroy cancer cells. Their innovative platform focuses on creating precision-designed treatments that offer enhanced safety and efficacy, aiming to revolutionize cancer therapy. Key Features and Functionality: - Unparalleled Safety: Utilizes selective infection and replication mechanisms to ensure therapies target only cancer cells, minimizing harm to healthy tissues. - Highly Lytic: Employs RNA viruses known for their potent ability to rapidly and effectively kill cancer cells. - Predictive Translation: Prioritizes models that translate effectively from in vitro studies to in vivo applications, facilitating smoother transitions to human treatments. - Maximized Therapeutic Duration: Engineers low immunogenicity into therapies to prevent premature neutralization by the immune system, extending their effectiveness. - Systemic Delivery: Designs treatments for systemic administration, enhancing the potential to address both primary tumors and metastatic sites. - Cost-Effective Production: Develops highly replicative viruses that are efficient to manufacture, making therapies more accessible. Primary Value and User Solutions: Humane Genomics addresses critical challenges in cancer treatment by offering therapies that combine high efficacy with exceptional safety profiles. Their engineered viruses are designed to selectively target cancer cells, reducing collateral damage to healthy tissues and potentially improving patient outcomes. By focusing on systemic delivery and low immunogenicity, their treatments aim to effectively combat both localized and metastatic cancers. Additionally, the cost-effective production methods employed by Humane Genomics strive to make advanced cancer therapies more accessible to a broader patient population.

Show More

When users leave Humane Genomics reviews, G2 also collects common questions about the day-to-day use of Humane Genomics. These questions are then answered by our community of 850k professionals. Submit your question below and join in on the G2 Discussion.

* * *

### 0.0

Nps Score

### All Humane Genomics Discussions

Search

Most CommentedMost HelpfulCommon QuestionsNewest

All DiscussionsDiscussions with CommentsCommon QuestionsDiscussions without Comments

FilterFilter

Filter byExpand/Collapse 

Sort by

Most Commented

Most Helpful

Common Questions

Newest

Filter by

All Discussions

Discussions with Comments

Common Questions

Discussions without Comments

Sorry...

There are no questions about Humane Genomics yet.

## Start a New Software Discussion

Have a software question?

Get answers from real users and experts

[Start A Discussion](/products/humane-genomics/discussions/new)

* * *

 ![Product Avatar Image](https://images.g2crowd.com/uploads/product/image/thumb_square/thumb_square_ccb54c1e58f85ffc39aa41f5aa05bd03/humane-genomics.jpg "Product Avatar Image")

### Have you used Humane Genomics before?

Answer a few questions to help the Humane Genomics community

[
Yes
](javascript:void(0))[
Yes
](https://www.g2.com/login?context=product_review&return_to=https%3A%2F%2Fwww.g2.com%2Fproducts%2Fhumane-genomics%2Fdiscuss%3Fsmall_ask%3Dhumane-genomics)
No